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Abstract We constructed an in vivo system to detect ransposi- 
tional rearrangements induced by the insertion sequence IS30. 
The transposase protein expressed from the transposase producer 
plasmids catalyzed rearrangements on different target sequences 
presented in trans. High yields, up to 83%, of transpositional 
frequencies were observed. The frequency of rearrangements 
correlated with the amount of transposase protein produced and 
the attractivity of the target sequences. Alteration in the 
frequency of transposition was observed in the recA-  E. coli 
strains JM109 and TG2. Remarkable structural and functional 
analogy was found with site-specific recombination systems. 
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by the genomic copies of the element) is too low to carry out 
transpositional reactions effectively; (2) the transposase pro- 
tein can act only in cis, i.e. on the same replicon from which it 
was produced - as was shown in the case of Tn5 [7-9]. 
To clarify this question we studied the in trans activity of 
the IS30 transposase in reactions characteristic of the element, 
and investigated the correlation between the expression level 
of IS30 transposase and the transpositional frequency. In our 
experiments the IS30 transposase was able to perform site- 
specific and 'classical' transpositional reactions in trans (di- 
merization and deletion, respectively), at very high frequen- 
cies, up to 82.7%. The system described here represents a
simple and useful tool in the isolation and characterization 
of mutants and in the development of an in vitro system. 
1. Introduction 
The insertion sequence IS30 (Fig. 1A) is a low copy number 
mobile genetic element residential in the K-12 and C strains of 
Escherichia coli [1]. The transposition of IS30 proceeds in a 
conservative pathway, via an intermediate that consists of two 
elements joining to each other with their left and right term- 
inal inverted repeats (IR) [2]. The highly unstable (IS30)2 in- 
termediate is formed by means of site-specific dimerization 
and mediates further DNA rearrangements characteristic of 
the element. IS30 appears to be bifunctional as it catalyzes 
site-specific reactions (dimerization) and 'classical' transposi- 
tional events: simple insertion, deletion, inversion and trans- 
positional fusion (cointegration). IS30 has a defined target 
specificity: natural hot spot sequences were described from 
lambda and P1 bacteriophages [2], but its own inverted re- 
peats are also preferred targets. The 1221 bp long element 
contains one large open reading frame (ORF-A, bp 63- 
1211) coding for the 44.3 kDa transposase protein (Fig. 1A) 
[3]. The promoter of the transposase gene, P3OA, overlaps 
with the left IR of the element [4,5]. The N-terminal part of 
the IS30 transposase (ORF-A-N) containing the DNA-bind- 
ing domain, placed under the control of the inducible tac 
promoter, was overproduced and purified [6]. 
It was previously demonstrated that the genomic copies of 
IS30 were unable to complement the mutations in the trans- 
posase gene (Olasz et al., manuscript submitted) [2]. The lack 
of detectable complementation can be explained in two ways: 
(1) the amount of available transposase protein (synthesized 
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2. Materials and methods 
2.1. Bacterial strains, media, enzymes and chemicals 
The experiments were carried out in the recA E. coli strains JM109 
[10] and TG2 [11]. LB medium was prepared as described by Miller 
[12]. The primary antibody used with an Amersham immunoblotting 
detection kit (RPN23) was developed against IS30 transposase. Anti- 
biotics were used in the following final concentrations: kanamycin 
(Km) 20 gg/ml; ampicillin (Ap) 150 gg/ml; chloramphenicol (Cm) 
20 gg/ml. All other DNA techniques were carried out according to 
Sambrook et al. [11]. The structure of the plasmids used in the experi- 
ments is shown in Fig. 1. 
2.2. Induction of the IS30 transposase 
TG2 colonies harboring the different transposase producer plasmids 
were grown for 18 h in 2 ml LB Ap at 37°C in a waterbath, with or 
without 0.01 mM IPTG induction. Cells were harvested, protein sam- 
pies were analyzed by SDS-PAGE (according to Laemmli [15]) and 
immunoblotting. The transposase fraction was determined using a 
UVP image analyzer and GelBase software. 
2.3. The measurement of the in trans activity of IS30 transposase 
The transposase producer plasmids pJKI 110, pJKI 132 and pJKl 154 
were introduced into JM 109 cells. One colony of each transformation 
was chosen to make competent cells that were subsequently trans- 
formed with one of the substrate plasmids pJKI216, pJKI213, 
pJKI225 or pTFA2. In the control reactions we omitted the first 
transformation step, thus the bacterial host contained no transposase 
producer plasmid. After selection for the Cm R phenotype of the sub- 
strate plasmids, three individual colonies from each category (corre- 
sponding to a unique transposase producer-substrate plasmid combi- 
nation) were picked and grown for 18 h in 2 ml LB Km at 37°C in a 
waterbath, with or without IPTG induction. Cells were harvested and 
plasmid DNA was purified. To detect he rearrangements in the sub- 
strate plasmids, it was necessary to separate the Cm s segregants from 
the original Cm a plasmids existing in the same cell, so the plasmid 
DNA population was introduced into TG2 cells. The transformants 
were spread on solid LB medium containing Km, incubated overnight 
at 37°C and replica-plated on LB Km and LB Cm plates. The Cm a 
and Cm s colonies were counted and the frequency of transpositional 
rearrangement was calculated as the ratio of Cm s versus all, i.e. Cm s 
+ Cm R colonies. Plasmid DNA was purified from at least 10 colonies 
in each category and analyzed by restriction mapping. 
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3. Results 
3.1. The construction of  the system 
To study the in trans activity of IS30 transposase, the fol- 
lowing criteria had to be fulfilled. (1) The transposase produc- 
ing ORF-A had to be separated from the possible transposi- 
tional target sequences, including the left and right inverted 
repeat of the element. Therefore, two groups of plasmids were 
constructed: the transposase producer replicons (Fig. 1B) con- 
tained the intact ORF of the IS30 transposase, but carried no 
target sequences: the left and right inverted repeats of the 
element were inactivated (see legend to Fig. l); the compatible 
substrate replicons (Fig. 1C) carried different ranspositional 
target sequences and produced no functional tranposase, (2) 
To obtain a higher level of expression and transpositional 
activity, and to be able to investigate the correlation between 
them, the original promoter of the ORF-A was replaced with 
the inducible tac promoter in the transposase producer plas- 
mid p JK I l l0  and pJKI132 (Fig. 1B). The cloned lacl q repres- 
sor gene provided tight control over the transposase expres- 
sion in pJKI132. The control plasmid pJKI154 contained no 
functional promoter egion. (3) It was crucial to develop a 
simple method to detect ranspositional rearrangements at a 
very low frequency. In the substrate plasmids, the transposi- 
tional reactions led to the loss of the Cm rt gene by means of 
transpositional deletion (pJKI225) or site-specific dimerization 
(pTFA2, pJKI213, pJKI216, see Fig. 3B), so the bacteria car- 
rying the original and rearranged substrate plasmids were ea- 
sily identified as Cm R and Cm s clones, respectively. 
3.2. The expression level of  lS30 transposase in the transposase 
producer plasmids 
To assure that the transposase producer plasmids were 
overexpressing the IS30 transposase, and to study the effect 
of induction, bacterial cells harboring the plasmids pJKI110, 
pJKI132 and pJKI154 were grown under inducing or non- 
inducing conditions. Samples were analyzed by SDS-PAGE 
and immunoblotting (Fig. 2). No transposase was detectable 
in the bacteria without transposase producer plasmids, 
although the host cells contained the genomic copies of 
IS30, or in the bacteria carrying pJKI154, where the P30A 
promoter was truncated. In the cells harboring the transpos- 
ase producer plasmids p JK I l l0  and pJKI132, in which the 
transposase gene was placed under the control of the tac pro- 
moter, the transposase r presented 17-21% of the total pro- 
tein under inducing conditions. From pJKI110 the same level 
of transposase was produced without IPTG induction, while 
in the case of pJKI132 the lacl q repressor effectively regulated 
the expression of the transposase gene. 
3.3. The measurement of  the in trans activity of  lS30 
One transposase producer and one substrate plasmid were 
introduced into the same recA- JM109 bacterial host. In this 
way, 16 transposase producer-substrate plasmid combination 
were created (we used 4 substrate and 3 transposase producer 
plasmids; in the control reaction there was no transposase 
producer plasmid). The bacteria were incubated under induc- 
ing or non-inducing conditions, and the transpositional fre- 
quencies were measured (see Section 2.3). The schematic re- 
presentation of the assay is shown in Fig. 3A, while the 
experimental data are presented in Table 1A. In the absence 
of any transposase producer plasmids, the background activ- 
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Fig. 1. The structure of IS30 (A), the transposase producer (B) and 
substrate (C) plasmids. A rectangle represents the IS30 sequence, 
the white and black triangles indicate the left and right inverted re- 
peats, respectively. The IS30 transposase protein is encoded by the 
ORF-A and transcribed from the P30A promoter (white arrow- 
head). ORF-A-N is coding for the N-terminal truncated part of the 
transposase (see Section 1). The transposase producer plasmids were 
derivatives of pAW380 [6], in which the original P30A promoter 
was deleted and substituted by the tac promoter (black arrowhead). 
The inactivation of the right IR of the element by the introduction 
of a new EcoRI site at 1216 bp (Olasz et al., manuscript submitted) 
and subsequent cloning steps resulted in pJKI110, in which the right 
IR was partially deleted (small black triangle). The insertion of the 
lacl ~ gene (dotted rectangle) from pDMI,1 [13] into pJKI110 yielded 
pJKI132. In pJKI154 the tac promoter was removed and the left IR 
was truncated (small white triangle), pJKI154 contained the IS30 se- 
quence from the unique Hincll site to the newly introduced EcoRI 
site (bp 17 1216). The substrate plasmids were pACYC177 deriva- 
tives, pTFA2 was a deletion product of pAW444 [2], and contained 
the Cm rt gene flanked by the right (bp 1115-1221) and the left ends 
(bp 1-459) of IS30. The three other substrate plasmids were 
pAW441 [2] derivatives and carried an (IS30)2 intermediate structure 
(bp 1115-459) and the lambda hot spot (LHS, small dark rectangle) 
from pAW782 [2] in pJKI225, the 120 bp fragment of pFOL553 
(unpublished) containing the right IR (bp 1115-1221)joined to the 
synthetic hot spot (LHS') in pJKI213, and another intermediate 
structure from pAW136 [14] in pJKI216. Abbreviations: Apa: Ap 
resistance gene (13-1actamase); Kmrt: Km resistance gene (aminoglu- 
coside-3'-phosphotransferase); cma: Cm resistance gene (chloram- 
phenicol acetyltransferase). Restriction sites: B: BamHI; B/Bg: 
BamHI-BglII hybrid recognition site; Bg: BgllI; C: ClaI; H: Hin- 
dill; Hi: HinclI; E: EcoRI; P: PstI; T: TthlllI; X: XbaI. 
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Fig. 2. SDS-PAGE (A) and immunoblot (B) analysis of the IS30 
transposase produced by the transposase producer plasmids. Bacter- 
ial hosts harboring the plasmids pJKI154, pJKIll0, pJKI132 or no 
transposase producer plasmid were incubated under inducing (+) 
and non-inducing ( - )  conditions (see Section 2.2). Protein samples 
were separated by SDS-PAGE (10% w/v gel) and blotted. Gel was 
stained with Coomassie blue (A), the immunoblot was developed 
with anti-IS30 transposase antibody (B) (MWS: molecular weight 
standard). 
ity (due to genomic copies of IS30) was very low: only one 
transpositional rearrangement was detected out of 23065 
cases investigated. The promoterless transposase producer 
plasmid pJKI154 also had very low activity (<0.04%), with 
the exception of pJKI216 as substrate plasmid, where five 
rearrangements were found in 6803 colonies, p JK I l l0  (con- 
taining the tac promoter) yielded transpositional ctivities in 
the range of 0.03-82.7%, and reached its maximum value with 
the substrate plasmid pJKI216 (carrying two intermediate 
structures), p JK I l l0  showed no response to induction: with 
the same substrate plasmid it resulted in 78.7% and 82.7% 
under inducing and non-inducing conditions, respectively. 
pJKI132 (containing the tac promoter and the lacI q gene) 
resulted in similar values ( < 0.03-57.6%), but due to the strin- 
gent control of the tac promoter the effect of induction was 
evident: the addition of IPTG doubled the transpositional 
frequency in the case of pJKI216 (from 29.4% to 57.6%). 
These findings are in agreement with the result of the induc- 
tion assay: the expression level of the transposase correlates 
with the transpositional frequency (see Section 3.2 and below). 
A significant rend was observed in the attractivity of the 
target sequences, too. pJKI216 (two intermediate structures) 
was the most active substrate plasmid, pJKI213 (an intermedi- 
ate structure and a right end joined to a synthetic LHS' se- 
quence) and pTFA2 (the 'inner' left and right inverted repeats 
of a transposon) were of the same activity, while pJKI225 (an 
intermediate structure and a LHS) proved to be the least 
active. High DNA rearrangement frequencies (9.1-82.7%0) 
were obtained with the combination of the transposase pro- 
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ducer plasmids pJKI 110 or pJKI 132 (in which the transposase 
was transcribed from the tac promoter) and the substrate 
plasmid pJKI216 (containing two intermediate structures). 
In the case of the same transposase producer plasmids the 
induction had no influence on the transpositional frequency 
with the less active substrate plasmids pTFA2, pJKI225 and 
pJKI213. This finding suggests that in these reactions it is 
presumably the target structure and not the amount of the 
transposase protein that determined the efficiency of the reac- 
tion. 
3.4. Alteration in the transpositional ctivity in different 
bacterial hosts 
To test the applicability of the system in other bacterial 
strains, the experimental procedure described in the previous 
section was repeated in the recA- strain TG2. The results are 
shown in Table 1B. The general tendencies were similar to the 
ones observed in JM109, with the same ranking being set 
among the transposase producer and substrate plasmids. 
However, the transpositional frequencies were lower in TG2 
compared to JM109, e.g. the values dropped to one-third and 
one-half with transposase producer plasmid pJKI132 (tac and 
laclq) and substrate plasmid pJKI216 (two intermediate struc- 
tures), and to one-eighth and one-tenth with transposase pro- 
ducer plasmid p JK I l l0  (tac) and substrate plasmid pTFA2 
(the left and right IR). There was only one case where the 
difference in the transpositional ctivities was insignificant: 
the transposase producer plasmid pJKI110 (tac) and the sub- 
strate plasmid pJKI216 (two intermediate structures) resulted 
in similar values in both strains under IPTG induction (TG2: 
76.5%, JM109: 78.7%). The phenomenon can be explained if 
we presume that we reached the 'saturation level' of the trans- 
positional reactions in the system. The fact that the same 
transposase producer-substrate plasmid combination 
(pJKI l l0  and pJKI216) showed no response to induction in 
JMI09, but did so in strain TG2, also supports this hypoth- 
esis: as the frequency of transposition was 82.7% in JM109 
under non-inducing conditions, it reached the 'saturation le- 
vel' and could not be increased further by induction, while in 
TG2 the transpositional frequency was able to grow from 
23.3% to 76.5% upon induction. 
3.5. The effect of  transcription level on the transpositional 
frequency 
To study the effect of induction on the frequency of trans- 
position, three TG2 colonies harboring the transposase pro- 
ducer plasmid pJKI132 and the substrate plasmid pJKI216 
were incubated in liquid media containing 0; 0.1; 1; 10; 50 
and 100 ktM IPTG, under the same conditions used in the 
measurement of the in trans activity (see Section 3.3 and 
Fig. 4). The addition of the inducer had no significant effect 
on the transpositional frequency until 1 ~tM. In the range of 
10-50 ~tM IPTG concentration, the frequency of rearrange- 
ment increased ramatically, until it had its maximum at 50 
ktM, then slightly declined, probably due to the lethal effects 
of the induction and the transpositional rearrangements. Rel- 
atively high transpositional ctivity (14%) was observed with- 
out induction of the transposase gene in pJKI132, despite the 
very small amount of transposase produced (Fig. 2), indicat- 
ing that the repression by the lacl q was not efficient in this 
respect. The results suggest hat little amount of IS30 trans- 
posase can effectively catalyze the transposition. 
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Fig. 3. The schematic presentation of the in vivo transpositional reaction between a transposase producer and substrate plasmid (A). The char- 
acteristic reactions of the different substrate plasmids (B). For abbreviations see Fig. 1. Site-specific dimerization designates the reaction which 
leads to the formation of an (IS30)2 intermediate structure [2]. The structure of the transpositional products was verified by restriction analysis. 
4. Discuss ion 
To study the in trans activity of the IS30 transposase two 
sets of plasmids were constructed: the transposase producer 
replicons expressed the intact protein, but carried no transpo- 
sitional target sequences. The substrate replicons contained 
different hot spot regions for the transposition of IS30, but 
produced no functional transposase. Each substrate plasmid 
was designed to assay one type of reaction (Fig. 3B) and to 
measure the different activities of site-specific dimerization 
(intermediate-formation) a d deletion separately. As various 
target sequences were offered for the same transposase produ- 
cer plasmid, a significant order was observed in the attractiv- 
ity of the targets (Fig. 1C, Table 1). High transpositional 
frequencies, 76.5-82.7%, were observed between the transpos- 
ase producer eplicons, which had the ORF-A under the con- 
trol of the tac promoter (pJKIl l0 and pJKI132) and the 
substrate replicon carrying two intermediate structures 
(pJKI216). In the control reactions (in the absence of the 
transposase producer plasmid or with the promoterless trans- 
posase producer plasmid pJKI154) only a few rearrangements 
were detected. The phenomenon that there was no comple- 
mentation with the chromosomal copies of IS30 is in good 
agreement with the data of previous experiments [2], and is 
presumably due to the low level of available transposase. 
Some differences in the transpositional frequency were ob- 
served in the two E. coli strains investigated. The comparison 
of the genetic background revealed no obvious explanation 
for this finding. The system, however, could be applied for 
the study of transpositional host factors. 
Other possible applications of the system: 
1. The verification of the in vivo complementation f IS30 
transposase was a step towards the construction of an in 
vitro system. Our substrate plasmids proved to be effi- 
cient for detecting different transpositional rearrange- 
ments, and enabled us to study the various reactions 
separately. 
2. The transposase producer plasmid pJKI132 can be used 
for the overexpression and purification of the IS30 
transposase protein, and therefore, also contributes to 
the development of the in vitro system. 
3. The high activity and reproducibility of the trans system 
provides a convenient assay to identify and characterize 
mutations in the transposase or in the hot spot se- 
quences. 
It is worth mentioning that our IS30 system shows remark- 
able analogies to the site-specific recombination systems, espe- 
cially in the case of pJKI216 (Fig. 3B). The joined IS30 ends 
have the characteristic features of a 'recombinogenic site': the 
(IS30)2 intermediate structure contains inverted DNA se- 
quences eparated by a spacing region, and the rearrangement 
between the two sites shows analogies to the excision of bac- 
teriophage lambda and to the resolution of Tn3-type transpo- 
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Fig. 4. The correlation between the transpositional frequency and 
the transcription level of the IS30 transposase gene. The transposi- 
tional frequency was measured as the ratio of Cm s versus all colo- 
nies (see Section 2.3 and Table 1) in the presence of different IPTG 
concentrations. 
sons, while the IS30 transposase protein plays the role of a 
'site-specific recombinase' (for review see [16,17]). The high 
frequency of rearrangements detected (above 80%) is also 
comparable to the efficiency of the site-specific recombinat ion 
systems. These considerations raise the possibility of an evo- 
lutionary relationship between the (IS)2 forming insertion se- 
quences (IS2 [18], IS21 [19,20], IS30 [2]) and certain site-spe- 
cific recombinat ion systems. 
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Table 1 
The transpositional frequencies with different ransposase producer-substrate plasmid combinations in JM109 (A) and TG2 (B) (see Sections 3.3 
and 3.4) 
Transposase Substrate 
producer plasmid 
plasmid 
No induction IPTG induction 
Number of colonies Transpositional Number of colonies Transpositional 
frequency (%) fequency(%) 
total Cm s total Cm s 
(A ) Transpositional frequencies in JMI09 
none pTFA2 1943 
pJKI225 3423 
pJKI213 3330 
pJKI216 3945 
pJKI154 pTFA2 3011 
pJKI225 3273 
pJKI213 3136 
pJKI216 3139 
pJKI l l0 pTFA2 3806 31 
pJKI225 2496 3 
pJKI213 1560 15 
pJKI216 1923 1590 
pJKI132 pTFA2 3457 30 
pJKI225 3612 0 
pJKI213 2492 16 
pJKI216 1464 431 
(B) Transpositional frequencies in TG 
none pTFA2 3498 
pJKI225 1332 
pJKI213 3903 
pJKI216 818 
pJKI154 pTFA2 271 0 
pJKI225 570 0 
pJKI213 2226 0 
pJKI216 450 0 
pJKIllO pTFA2 932 0 
pJKI225 824 0 
pJKI213 1568 9 
pJKI216 1034 241 
pJKI132 pTFA2 1504 3 
pJKI225 572 0 
pJKI213 2283 5 
pJKI216 1246 114 
0 < 0.05 2408 0 < 0.04 
0 < 0.03 4773 0 < 0.02 
0 < 0.03 1855 0 <0.05 
1 0.02 1388 0 < 0.07 
0 <0.03 3324 0 < 0.03 
0 <0.03 3633 0 <0.03 
0 <0.03 2317 0 < 0.04 
2 0.06 3664 3 0.08 
0.81 3461 27 0.78 
0.12 3436 1 0.03 
0.96 3138 36 1.13 
82.68 2588 2037 78.71 
0.87 2491 17 0.68 
<0.03 3225 2 0.06 
0.64 3259 28 0.86 
29.44 2441 1405 57.56 
0 < 0.02 1911 0 < 0.05 
0 < 0.07 1143 0 <0.08 
0 < 0.02 3766 2 0.05 
1 0.12 1798 0 < 0.05 
< 0.36 323 0 <0.31 
<0.17 527 0 < 0.19 
<0.04 2198 0 <0.04 
< 0.22 1564 0 <0.06 
<0.11 1191 0 < 0.08 
< 0.12 2088 0 < 0.04 
0.57 1534 4 0.26 
23.30 612 468 76.47 
0.20 3587 11 0.31 
< 0.17 1376 1 0.07 
0.22 3448 8 0.23 
9.15 1956 524 26.79 
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